| __timestamp | Bio-Techne Corporation | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 22746000000 |
| Thursday, January 1, 2015 | 144969000 | 21536000000 |
| Friday, January 1, 2016 | 162364000 | 21685000000 |
| Sunday, January 1, 2017 | 188462000 | 25354000000 |
| Monday, January 1, 2018 | 210850000 | 27091000000 |
| Tuesday, January 1, 2019 | 240515000 | 27556000000 |
| Wednesday, January 1, 2020 | 255497000 | 28427000000 |
| Friday, January 1, 2021 | 298182000 | 23402000000 |
| Saturday, January 1, 2022 | 349103000 | 24596000000 |
| Sunday, January 1, 2023 | 366887000 | 26553000000 |
| Monday, January 1, 2024 | 389335000 | 27471000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of healthcare, cost efficiency remains a pivotal factor for success. This analysis juxtaposes the cost of revenue efficiency between two industry titans: Johnson & Johnson and Bio-Techne Corporation, from 2014 to 2023. Over this decade, Johnson & Johnson consistently maintained a cost of revenue around 25 billion USD, showcasing a stable financial strategy. In contrast, Bio-Techne Corporation, a smaller yet dynamic player, demonstrated a remarkable growth trajectory, with its cost of revenue increasing by approximately 266% from 2014 to 2023. This growth reflects Bio-Techne's aggressive expansion and investment in innovation. Notably, the data for 2024 is incomplete, highlighting the need for continuous monitoring. As the healthcare sector faces new challenges, understanding these financial dynamics is crucial for stakeholders aiming to navigate the complexities of cost management.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Gilead Sciences, Inc.
Cost of Revenue Comparison: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Johnson & Johnson vs Viatris Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Johnson & Johnson vs Galapagos NV: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Bio-Techne Corporation
Analyzing Cost of Revenue: Bio-Techne Corporation and BioMarin Pharmaceutical Inc.
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.'s Expenses
Bio-Techne Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored